Tag: Oncology
University of Warwick’s study highlights risks in AI cancer pathology tools
The research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals
IIT Madras, Karkinos Healthcare study reveals 1 in 4 Indian breast...
One of the largest Indian germline studies, it shows that a majority of inherited risk lies beyond ‘BRCA1/2’ (Breast Cancer Genes 1 & 2), highlighting the need for multi-gene testing, ancestry-specific databases and precision oncology guidelines
4baseCare raises Rs 90 Cr in Series B first close led...
The funding will be used towards expansion into new geographies and to scale its AI powered precision oncology platform, OncoTwin
Roche Pharma India announces recipients of the 2nd Edition of LEAP...
Each winner was awarded INR 3 lakh scholarship, a certificate, and medal for their contributions to advancing academic excellence in oncology
C Com Digital to spearhead digital transformation at Onco-Life Cancer Centre,...
C Com Digital will build Onco-Life’s brand, launch a bilingual website, and drive social media campaigns for wider outreach
Ichnos Glenmark Innovation and AbbVie announce exclusive global licensing agreement for...
IGI’s lead investigational asset, ISB 2001, has been developed using IGI’s proprietary BEAT® protein platform, for oncology and autoimmune diseases
Servier India launches Tibsovo® – First-in-class targeted therapy for rare IDH1-mutated...
Marks an important development in oncology, providing a treatment option for patients with AML and cholangiocarcinoma in India
Health Minister inaugurates second AIIMS Oncology Conclave 2025 at NCI-AIIMS, Jhajjar
The AIIMS Oncology Conclave aimed to bring together leading experts in oncology across all the Institute of National Importance (INIs) of India
AIIMS Jammu partners 4baseCare to host Precision Oncology Expert Meet
POEM-2025 hosted a series of panel discussions, case-based studies, and expert insights focused on leveraging advanced technology for better patient outcomes
Australia oncology devices market to grow by 3% CAGR through 2033,...
Australia accounted for around 10% of the Asia-Pacific (APAC) oncology devices market in 2024, driven by the strong research initiatives and increased government investment